Living Cell Technologies Ltd
ASX:LCT

Watchlist Manager
Living Cell Technologies Ltd Logo
Living Cell Technologies Ltd
ASX:LCT
Watchlist
Price: 0.012 AUD Market Closed
Market Cap: 19.6m AUD

Operating Margin
Living Cell Technologies Ltd

-4 967.8%
Current
-25 099%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4 967.8%
=
Operating Profit
-2.1m
/
Revenue
42k

Operating Margin Across Competitors

No Stocks Found

Living Cell Technologies Ltd
Glance View

Market Cap
18.7m AUD
Industry
Biotechnology

Living Cell Technologies Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is focused on discovering and developing treatments for conditions, such as Parkinson's disease, diabetes, obesity and migraine. The firm's product pipeline consists of LP-003 for anti-obesity, LC-002 for migraine treatment and NTCELL for Parkinson's disease. Its Long-acting Pramlintide, LP-003 is a peptide drug that reduces caloric intake targeting obesity and it is also used for the treatment of diabetes. LC-002, is a receptor blocker targeting calcitonin gene-related peptide (CGRP), a neuropeptide hormone found in the nervous system. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells targeting Parkinson's disease. NTCELL's choroid plexus cells are coated with LCT's IMMUPEL technology to protect them from attack by the immune system. The company has completed Phase I/IIa clinical trial and phase IIb trials for mid- to late-stage Parkinson's disease.

LCT Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4 967.8%
=
Operating Profit
-2.1m
/
Revenue
42k
What is the Operating Margin of Living Cell Technologies Ltd?

Based on Living Cell Technologies Ltd's most recent financial statements, the company has Operating Margin of -4 967.8%.

Back to Top